Willingness to Participate and Enroll in a Phase 3 Preventive HIV-1 Vaccine Trial

Abstract

Improving community and participant knowledge about preventive HIV vaccine trials may help ensure informed consent. However, whether informing potential participants will reverse or contribute to the declining trend in WTP observed in this cohort warrants further investigation.